Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.97)
# 2,956
Out of 4,876 analysts
96
Total ratings
30.53%
Success rate
-3.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.70 | +196.30% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.28 | +250.32% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.18 | +747.46% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $7.40 | +440.54% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.40 | +614.29% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.31 | +358.02% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.84 | +168.60% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.73 | +172.48% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $2.88 | +698.61% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $25.95 | +189.02% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $6.47 | +456.41% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.48 | +141.94% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.02 | +1,370.59% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.66 | +583.06% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $35.81 | +39.63% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.36 | +194.12% | 11 | Nov 11, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.70
Upside: +196.30%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.28
Upside: +250.32%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.18
Upside: +747.46%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $7.40
Upside: +440.54%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.40
Upside: +614.29%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $1.31
Upside: +358.02%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.84
Upside: +168.60%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.73
Upside: +172.48%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $2.88
Upside: +698.61%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $25.95
Upside: +189.02%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $6.47
Upside: +456.41%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.48
Upside: +141.94%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.02
Upside: +1,370.59%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $3.66
Upside: +583.06%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $35.81
Upside: +39.63%
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.36
Upside: +194.12%